Leptomeningeal Disease clinical trials
6 active trials name this condition. Describe your situation to see which ones you may be eligible for.
- Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- Establishing Daily Applicable Parameters for Using Magnetic Resonance Spectroscopy of Spinal Cord
- Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal Disease
- Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivolumab for Her- BC LMD
- A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)
- A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Leptomeningeal Disease” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.